Codman Certas Programmable Valve In Line Valve with SiphonGuard Device, Unitized Bactiseal Catheter and Accessories Product Code: 82-8807 Product Usage: The CODMAN CERTAS Programmable Valve is an implantable device that provides constant intraventricular pressure and drainage of CSF (cerebrospinal fluid) for the management of hydrocephalus. The valve can be set to a choice of eight opening pressure settings for constant intraventricular perssure drainage of CSF. The CODMAN CERTAS Therapy Management System (TMS) allows the non-invasive reading or adjustment of the valve setting.
Published February 5, 2014 · Recall initiated: May 16, 2013
Summary
FDA records medical device Class II recall Z-0864-2014, published February 5, 2014 and initiated May 16, 2013. Recalling firm: Codman & Shurtleff, Inc.; Status: Terminated; Reported quantity: 746 units; Lot: Lot Codes: CLPCNB CMBCPT CMCC2W CMDB6L CMDDJV CMKB24 CMLCKN CMMC3H CMNBZH CNCB6N CNCCLJ CNCCZ3 CNDB8C CNDBRJ CNGBK4 CNHCZR CNJB1G CNJC4T CNJCMR CNKBZD CNLBVM CNLBZC CNMBFL CNNDH1 CNMBFM CNMDNK CNPBRL CNPCLV CPBBGT CNCCLH CNCCZ2 CNDB69 CNDCV0 CPBCR3 CPCBHC CPCBHD CPDCC3 CMMCGV CNBB11 CPBCR4 CPCCMN CPDBYL. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Codman Certas Programmable Valves used for hydrocephalus may not operate properly
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Codman & Shurtleff, Inc.
- Distributor
- Worldwide Distribution - US Nationwide, Australia, Austria, Belgium, Brazil, Switzerland, Czech Republic, Germany, Spain, Finland, France, Great Britain, Israel, Italy, Netherlands, Norway, Portugal, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey, South Africa, and UK.
- Lot
- Lot Codes: CLPCNB CMBCPT CMCC2W CMDB6L CMDDJV CMKB24 CMLCKN CMMC3H CMNBZH CNCB6N CNCCLJ CNCCZ3 CNDB8C CNDBRJ CNGBK4 CNHCZR CNJB1G CNJC4T CNJCMR CNKBZD CNLBVM CNLBZC CNMBFL CNNDH1 CNMBFM CNMDNK CNPBRL CNPCLV CPBBGT CNCCLH CNCCZ2 CNDB69 CNDCV0 CPBCR3 CPCBHC CPCBHD CPDCC3 CMMCGV CNBB11 CPBCR4 CPCCMN CPDBYL
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACodman EDS 3 Drainage System (no Ventricular Catheter) (External Drainage System) Catalog Number: 82-1731October 29, 2014
- FDACodman EDS 3 Drainage System with Ventricular Catheter (External Drainage System) Catalog Number: 82-1730October 29, 2014
- FDACodman Lumbar Drainage Catheter Kit II with EDS 3 (External Drainage System) Catalog Number: 82-1738 IndicatedOctober 29, 2014
- FDACodman Certas - In Line Valve only with SIPHONGUARD® Device; Product Code: 82-8804 The Codman CertasAugust 20, 2014
- FDACodman Certas Programmable Valve In Line Valve with Siphonguard, Unitized Catheter and Accessories ProductFebruary 5, 2014
- FDAThe Centricity Laboratory System is intended to be an information system designed to support the clinical andFebruary 5, 2014
Questions about this recall
Was Codman Certas Programmable Valve In Line Valve with SiphonGuard Device, Unitized Bactiseal Catheter and Accessories Product Code: 82-8807 Product Usage: The CODMAN CERTAS Programmable Valve is an implantable device that provides constant intraventricular pressure and drainage of CSF (cerebrospinal fluid) for the management of hydrocephalus. The valve can be set to a choice of eight opening pressure settings for constant intraventricular perssure drainage of CSF. The CODMAN CERTAS Therapy Management System (TMS) allows the non-invasive reading or adjustment of the valve setting. recalled?
Yes. FDA published recall Z-0864-2014 on February 5, 2014. Reported hazard: Codman Certas Programmable Valves used for hydrocephalus may not operate properly
What should I do if I have this product?
Voluntary: Firm initiated · Letter